English Archives | SenzaGen

SenzaGen further strengthens US market position with 1.5 MSEK order from global chemical industry leader

SenzaGen opens expanded laboratory facilities to strengthen capacity in line with 2030 growth plan

UK signals shift to non-animal testing – new opportunities for SenzaGen

SenzaGen secures order worth SEK 2.5 million from leading global tech company

SenzaGen presents growth plan and strategic priorities at Capital Markets Day

SenzaGen’s interim report January–September 2025 | Growth and break-even in Q3

Invitation to the presentation of SenzaGen’s Q3 2025 interim report

SenzaGen secures orders of SEK 1.3 million from a US-based world-leading chemical company

SenzaGen invites to Capital Markets Day in Stockholm on November 10, 2025

SenzaGen secures new follow-up order worth approx. 1.0 MSEK for GARD® from a global leading U.S. pharmaceutical company

Subscribe

Prenumerera